Part:BBa_K4768008

Split T7 RNA polymerase (Nterm) conjugated to Pertuzumab with a transmembrane linker

Part for Expression of the T7 RNA polymerase (Nterm) conjugated to Pertuzumab with a transmembrane linker ZipA

Sequence and Features

Assembly Compatibility:

• 10
  INCOMPATIBLE WITH RFC[10]

  Illegal EcoRI site found at 987
  Illegal XbaI site found at 40
  Illegal SpeI site found at 1147
  
• 12
  INCOMPATIBLE WITH RFC[12]

  Illegal EcoRI site found at 987
  Illegal SpeI site found at 1147
  
• 21
  INCOMPATIBLE WITH RFC[21]

  Illegal EcoRI site found at 987
  
• 23
  INCOMPATIBLE WITH RFC[23]

  Illegal EcoRI site found at 987
  Illegal XbaI site found at 40
  Illegal SpeI site found at 1147
  
• 25
  INCOMPATIBLE WITH RFC[25]

  Illegal EcoRI site found at 987
  Illegal XbaI site found at 40
  Illegal SpeI site found at 1147
  Illegal AgeI site found at 1200
  
• 1000
  INCOMPATIBLE WITH RFC[1000]

  Illegal BsaI.rc site found at 21
  Illegal SapI.rc site found at 1836
  

       <figure class="normal mx-auto">    
           <img
           class="d-block"
           style="width:90%;"
           src=""> 
           <figcaption class="normal">Figure 1: NT7-ZipA-Pertuzumab structure.</figcaption>
       </figure>

Introduction

The CALIPSO part BBa_K4768008 is composed of the N-terminal subunit of the T7 RNA polymerase (residues 1 to 180) fused to the anti-HER2 antibody Pertuzumab through an optimized linker sequence containing a transmembrane domain. This gene is under transcriptional control of an SP6 promoter and T7 terminator.

This part, coupled to the part BBa_K4768007 containing the C-terminal subunit of the T7 RNA polymerase, has been designed to develop a split T7 RNAP-based biosensor capable of recognizing HER-2, an epidermal growth factor that is overexpressed in cancer cells. This biosensor will be incorporated into the liposome membrane to detect cancer cells via HER2-targeting antibodies and activate the expression of a gene of interest inside the liposome.

The HER2-induced T7 RNAP complex was designed from two existing constructs: a split T7 RNAP-based biosensor for the detection of rapamycin and a split luciferase conjugated with antibodies capable of recognizing HER2. We decided to merge the relevant functionalities of these two constructs and created a new biosensor that transduces HER2 binding to gene expression activation.

The part BBa_K4768008 was only studied in silico by molecular modeling to optimize the transmembrane linker for adequate flexibility.

Construction

TXXXXXX.

Molecular Modeling

TXXXXXX.

Characterisation

TXXXXXX.

Conclusion and Perspectives

TXXXXXX.

References

1. article 1 xxxxxxxx
2. article 2 xxxxxxx